529 Million People Living With Diabetes Worldwide in 2021
More than 1.31 billion projected to have diabetes by 2050, with almost half of countries having age-standardized rate greater than 10%.
More than 1.31 billion projected to have diabetes by 2050, with almost half of countries having age-standardized rate greater than 10%.
Recent FDA approvals include treatments for chronic migraine, type 1 diabetes, blood cancers, tardive dyskinesia and chorea associated with Huntington disease, vasomotor symptoms of menopause, pain and fever, and Fabry disease.
The iLet Bionic Pancreas uses an adaptive closed-loop algorithm requiring only a user’s body weight for start-up and no additional insulin dosing parameters.
Findings persist even after controlling for adverse neighborhood conditions.
Those with type 1 diabetes are least likely to increase physical activity, reduce caloric intake to manage overweight or obesity.
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Tzield is anti-CD3 monoclonal antibody that has been shown to preserve beta cell function, reducing the need for exogenous insulin.
Variation seen among subgroups, with rationing in 11.2% of those aged 65 years and older and 20.4% of younger persons.
Researchers compare the reduction in glycated hemoglobin level with use of a bionic pancreas compared with standard care in children and adults with type 1 diabetes.